Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Oliver Linsell"'
Autor:
Paul L Morrow, Simon Stables, Kilak Kesha, Rexson Tse, Diana Kappatos, Rishi Pandey, Sarah Russell, Oliver Linsell, Mary Jane McCarthy, Amy Spark, Dianne Vertes, Yvonne Triggs, Sinead McCarthy, Nanise Cuthers, Richard Massey
Publikováno v:
EClinicalMedicine, Vol 25, Iss , Pp 100460- (2020)
Background: AMB-FUBINACA is a synthetic cannabinoid that has been associated with periodic outbreaks of acute poisonings, but few fatalities. In late May, June and July 2017 Auckland, New Zealand, experienced an outbreak of deaths associated with AMB
Externí odkaz:
https://doaj.org/article/6384bb83bc564ca392176eecd93ad196
Autor:
Sinead McCarthy, Mary Jane McCarthy, Oliver Linsell, Nanise Cuthers, Richard Massey, Kilak Kesha, Diana C Kappatos, Yvonne Triggs, Paul Morrow, Rishi Pandey, Dianne Vertes, Simon Stables, Amy Spark, Sarah G G Russell, Rexson Tse
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 25, Iss, Pp 100460-(2020)
EClinicalMedicine, Vol 25, Iss, Pp 100460-(2020)
Background AMB-FUBINACA is a synthetic cannabinoid that has been associated with periodic outbreaks of acute poisonings, but few fatalities. In late May, June and July 2017 Auckland, New Zealand, experienced an outbreak of deaths associated with AMB-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a198aa53b035846d955f0f6087835a56
https://pubmed.ncbi.nlm.nih.gov/32743487
https://pubmed.ncbi.nlm.nih.gov/32743487
Autor:
John C. Ashton, Oliver Linsell
Publikováno v:
NeuroReport. 25:796-800
Hypoxia-ischemia (HI) is a model of cerebral ischemia used to model neonatal hypoxia and to study brain damage. Interpreting the results of experiments that use HI rests partly on the assumption that only the brain suffers major damage. In this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a379fd3c62f0ea8b9bdcef94b9847d4c
https://doi.org/10.1097/wnr.0000000000000190
https://doi.org/10.1097/wnr.0000000000000190
Publikováno v:
Journal of drug targeting. 23(4)
Cannabinoid receptor agonists are moderately effective at reducing neuropathic pain but are limited by psychoactivity. We developed a styrene maleic acid (SMA) based on the cannabinoid WIN 55,212-2 (WIN) and tested in a rat model of neuropathic pain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e809b764cd954925359df85d30deb1f5
https://pubmed.ncbi.nlm.nih.gov/25541465
https://pubmed.ncbi.nlm.nih.gov/25541465